Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Scholar Rock Holding
(NASDAQ:SRRK)
Intraday
$14.09
0
[0.00%]
After-Hours
$14.09
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$14.09
0
[0.00%]
At close: Apr 24
$14.09
0
[0.00%]
PreMarket: 4:00PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Scholar Rock Holding Stock (NASDAQ:SRRK)
Scholar Rock Holding Stock (NASDAQ: SRRK)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, April 03, 2024
Truist Securities Reiterates Buy on Scholar Rock Holding, Maintains $20 Price Target
Benzinga Newsdesk
-
Apr 3, 2024, 9:42AM
Thursday, March 28, 2024
Scholar Rock Is A Potential M&A Target, Its Exploration of Obesity Market Garners Interest: Analyst
Vandana Singh
-
Mar 28, 2024, 2:42PM
Scholar Rock Holding shares are trading higher after Raymond James initiated coverage on the stock with a Strong Buy rating and announced a $30 price target.
Benzinga Newsdesk
-
Mar 28, 2024, 12:36PM
Raymond James Initiates Coverage On Scholar Rock Holding with Strong Buy Rating, Announces Price Target of $30
Benzinga Newsdesk
-
Mar 28, 2024, 7:16AM
Tuesday, March 26, 2024
Piper Sandler Maintains Overweight on Scholar Rock Holding, Maintains $28 Price Target
Benzinga Newsdesk
-
Mar 26, 2024, 8:27AM
Monday, March 25, 2024
Truist Securities Reiterates Buy on Scholar Rock Holding, Maintains $20 Price Target
Benzinga Newsdesk
-
Mar 25, 2024, 12:19PM
Tuesday, March 19, 2024
Scholar Rock shares are trading higher after the company reported FY23 financial results.
Benzinga Newsdesk
-
Mar 19, 2024, 11:18AM
HC Wainwright & Co. Reiterates Buy on Scholar Rock Holding, Maintains $30 Price Target
Benzinga Newsdesk
-
Mar 19, 2024, 10:44AM
Scholar Rock Reports FY23 EPS Loss of $(1.99) Vs $(2.26) YoY and Cash Balance of $279.9M
Benzinga Newsdesk
-
Mar 19, 2024, 7:03AM
Tuesday, March 05, 2024
NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
-
Mar 5, 2024, 10:56AM
Tuesday, February 06, 2024
Scholar Rock Presents New Preclinical Data Demonstrating Potential Benefit Of SRK-439 For Healthy Weight Loss Management
Benzinga Newsdesk
-
Feb 6, 2024, 8:15AM
Thursday, January 25, 2024
Scholar Rock Announces Presentation Of New Preclinical Data Evaluating SRK-439 In Obesity At Keystone Symposia
Benzinga Newsdesk
-
Jan 25, 2024, 8:06AM
Tuesday, January 23, 2024
Scholar Rock Announces FDA Clearance Of IND Application To Initiate Phase 2 Proof-of-Concept Trial With Apitegromab To Treat Obesity
Benzinga Newsdesk
-
Jan 23, 2024, 8:02AM
Thursday, January 04, 2024
Scholar Rock Provides 2024 Corporate Update And Priorities
Benzinga Newsdesk
-
Jan 4, 2024, 8:30AM
Friday, November 24, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Nov 24, 2023, 4:31PM
Tuesday, November 07, 2023
Scholar Rock Holding Q3 2023 EPS $(0.53) Misses $(0.52) Estimate
Benzinga Newsdesk
-
Nov 7, 2023, 7:25AM
Earnings Scheduled For November 7, 2023
Benzinga Insights
-
Nov 7, 2023, 6:34AM
Friday, November 03, 2023
Scholar Rock Presents New Data From Phase 1 DRAGON Trial Showing Anti-Tumor Activity In Anti-PD-1 Resistant Metastatic CcRCC Patients And Supporting SRK-181 Continued Tolerability
Benzinga Newsdesk
-
Nov 3, 2023, 4:01PM
Wednesday, October 25, 2023
Scholar Rock shares are trading higher after Jefferies upgraded the stock from Hold to Buy and announced a $20 price target.
Benzinga Newsdesk
-
Oct 25, 2023, 2:03PM
Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Oct 25, 2023, 1:49PM
General Dynamics, Microsoft, Waste Management And Other Big Stocks Moving Higher On Wednesday
Lisa Levin
-
Oct 25, 2023, 11:29AM
Jefferies Upgrades Scholar Rock Holding to Buy, Announces $20 Price Target
Benzinga Newsdesk
-
Oct 25, 2023, 4:38AM
Thursday, October 19, 2023
10% Owner of Scholar Rock Holding Purchased $15.00M In Stock
Benzinga Insights
-
Oct 19, 2023, 11:03AM
Scholar Rock Holding Insider Trades Send a Signal
Benzinga Insights
-
Oct 19, 2023, 11:03AM
Scholar Rock To Present Clinical And Biomarker Data From The Phase 1 DRAGON Trial At The SITC 38th Annual Meeting
Benzinga Newsdesk
-
Oct 19, 2023, 8:18AM
Tuesday, October 17, 2023
Over $15M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
Lisa Levin
-
Oct 17, 2023, 7:05AM
Thursday, October 12, 2023
Why InMode Shares Are Trading Lower By 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Oct 12, 2023, 12:55PM
Domino's, Walgreens, Fastenal And Other Big Stocks Moving Higher On Thursday
Lisa Levin
-
Oct 12, 2023, 11:52AM
HC Wainwright & Co. Reiterates Buy on Scholar Rock Holding, Maintains $30 Price Target
Benzinga Newsdesk
-
Oct 12, 2023, 6:55AM
Scholar Rock Prices Upsized $85M Public Offering Of 12,408,760 Common Shares At $6.85/Share
Benzinga Newsdesk
-
Oct 12, 2023, 2:57AM
Wednesday, October 11, 2023
Scholar Rock Commences Public Offering For $75M Of Shares Of Its Common Stock
Benzinga Newsdesk
-
Oct 11, 2023, 5:10PM
Scholar Rock Plans To Advance Antimyostatin Program To Develop Novel Therapies For Cardiometabolic Disorders
Benzinga Newsdesk
-
Oct 11, 2023, 4:46PM
Friday, October 06, 2023
Why CalAmp Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Oct 6, 2023, 1:59PM
NuScale Power, Stagwell And Other Big Stocks Moving Higher On Friday
Lisa Levin
-
Oct 6, 2023, 12:10PM
Tuesday, September 19, 2023
Scholar Rock Announces Completion Of Enrollment For The Phase 3 SAPPHIRE Trial; Topline Data From Phase 3 Trial Expected In Q4 2024
Benzinga Newsdesk
-
Sep 19, 2023, 8:03AM
Thursday, August 10, 2023
Scholar Rock Holding Corporation shares are trading higher after the company reported better-than-expected Q2 EPS results.
Benzinga Newsdesk
-
Aug 10, 2023, 3:15PM
Wedbush Reiterates Outperform on Scholar Rock Holding, Maintains $24 Price Target
Benzinga Newsdesk
-
Aug 10, 2023, 9:44AM
HC Wainwright & Co. Reiterates Buy on Scholar Rock Holding, Maintains $30 Price Target
Benzinga Newsdesk
-
Aug 10, 2023, 7:46AM
Wednesday, August 09, 2023
Scholar Rock Holding Q2 EPS $(0.47) Beats $(0.55) Estimate
Benzinga Newsdesk
-
Aug 9, 2023, 5:03PM
Thursday, July 13, 2023
Wedbush Reiterates Outperform on Scholar Rock Holding, Maintains $24 Price Target
Benzinga Newsdesk
-
Jul 13, 2023, 8:17AM
HC Wainwright & Co. Reiterates Buy on Scholar Rock Holding, Maintains $30 Price Target
Benzinga Newsdesk
-
Jul 13, 2023, 6:06AM
Friday, June 30, 2023
Scholar Rock's New 36-Month Apitegromab Extension Data Reinforce Long-Term Substantial And Sustained Improvement Of Motor Function In Phase 2 TOPAZ Trial Patients With Nonambulatory Spinal Muscular Atrophy
Happy Mohamed
-
Jun 30, 2023, 11:01AM
Monday, June 26, 2023
Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Jun 26, 2023, 12:31PM
Tuesday, May 09, 2023
Scholar Rock Holding Q1 EPS $(0.49) Down From $(0.21) YoY; $275M In Cash, Cash Equivalents, And Marketable Securities Expected To Fund Operations Into 2025
Benzinga Newsdesk
-
May 9, 2023, 8:01AM
Wednesday, May 03, 2023
Scholar Rock Holding 10% Owner Trades $202K In Company Stock
Benzinga Insights
-
May 3, 2023, 11:06AM
Monday, April 03, 2023
Piper Sandler Assumes Scholar Rock Holding at Overweight, Announces Price Target of $26
Benzinga Newsdesk
-
Apr 3, 2023, 9:15AM
Friday, March 10, 2023
Why JAKKS Pacific Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Mar 10, 2023, 12:58PM
Wednesday, March 08, 2023
HC Wainwright & Co. Reiterates Buy on Scholar Rock Holding, Maintains $30 Price Target
Benzinga Newsdesk
-
Mar 8, 2023, 6:07AM
Tuesday, March 07, 2023
Scholar Rock Holding Corporation FY22 Revenue $33.2M, Up From $18.8M YoY
Benzinga Newsdesk
-
Mar 7, 2023, 7:15AM
Monday, March 06, 2023
US Stocks Could Consolidate As S&P 500, Nasdaq Futures Tick Up Ahead Of Fed Chair Powell's Congressional Testimony
Shanthi Rexaline
-
Mar 6, 2023, 6:36AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch